The market sold off and took a number of biotechs with it, although there were some that bucked the trend. I would not read anything into the selling today as.
Well, I think it was more of the same in the sector writ large with the biggest news obviously being SRPT, which I will touch on below. I was surprised.
A mixed day in the market which was nice to see a day in which not all stocks were moving in the same direction. Obviously had some stock specific news.
While I wanted some more news from the biotech sector this was not exactly what I was planning. I discuss my thoughts on ARIA in an article on the street,.
There was some nice action in biotech land today despite not being particularly busy in terms of news. There was some interesting stock specific action and the sector was a.
Well, it was certainly a news filled evening and it will take a couple of days to sort through it all, so today will be a first cut. In general.
Well, there was not a lot of news out there in biotech land but oddly there is a lot I want to talk about and will work through it over.
This is midday today as I will be out of my office for the rest of the day. So an early surprise. A very odd day today in the market..
Really another slow day entering into the long weekend. From my perspective, there were really only two really interesting moves. 1. AVEO was a bit of a shocker. AVEO disclosed.
While the market got some intraday whipsaw action, it seemed generally good and biotechs did well- early. We had a late day sell-off with biotechs seeming to do better than.
Outside of a not completely unexpected merger, it was a relatively quite start to the week. As has been par for the course, ASCO oncology stocks tended to be weak.
The following stocks had notable activity in their options during the past week: $OPTR (5/13): 2,250 SEP 17.50 strike Calls were sold against equal number of purchased JUN 12.5 Puts.